The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Virulence of a Mycobacterium tuberculosis clinical isolate in mice is determined by failure to induce Th1 type immunity and is associated with induction of IFN-α/β
Open accessAbstract
To understand how virulent mycobacteria subvert host immunity and establish disease, we examined the differential response of mice to infection with various human outbreak Mycobacterium tuberculosis clinical isolates. One clinical isolate, HN878, was found to be hypervirulent, as demonstrated by unusually early death of infected immune-competent mice, compared with infection with other clinical isolates. The differential effect on survival required lymphocyte function because severe combined immunodeficiency (SCID) mice infected with HN878 or other clinical isolates all died at the same rate. The hypervirulence of HN878 was associated with failure to induce M. tuberculosis-specific proliferation and IFN-γ production by spleen and lymph node cells from infected mice. In addition, 2- to 4-fold lower levels of tumor necrosis factor-α (TNF-α), IL-6, IL-12, and IFN-γ mRNAs were observed in lungs of HN878-infected mice. IL-10, IL-4, and IL-5 mRNA levels were not significantly elevated in lungs of HN878 infected mice. In contrast, IFN-α mRNA levels were significantly higher in lungs of these mice. To further investigate the role of Type 1 IFNs, mice infected with HN878 were treated intranasally with purified IFN-α/β. The treatment resulted in increased lung bacillary loads and even further reduced survival. These results suggest that the hypervirulence of HN878 may be due to failure of this strain to stimulate Th1 type immunity. In addition, the lack of development of Th1 immunity in response to HN878 appears to be associated with increased induction of Type 1 IFNs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sturgill-Koszycki, S., Schlesinger, P. H., Chakraborty, P., Haddix, P. L., Collins, H. L., Fok, A. K., Allen, R. D., Gluck, S. L., Heuser, J., & Russell, D. G. (1994) · Science · doi:10.1126/science.8303277 · Cited by 1,302
A Mutation in the Interferon-γ –Receptor Gene and Susceptibility to Mycobacterial Infection
Newport, M. J., Huxley, C. M., Huston, S., Hawrylowicz, C. M., Oostra, B. A., Williamson, R., & Levin, M. (1996) · New England Journal of Medicine · doi:10.1056/nejm199612263352602 · Cited by 1,199
Merriam-Webster's collegiate dictionary
(2004) · Choice Reviews Online · doi:10.5860/choice.41-2515 · Cited by 1,049
Sreevatsan, S., Pan, X., Stockbauer, K. E., Connell, N. D., Kreiswirth, B. N., Whittam, T. S., & Musser, J. M. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.18.9869 · Cited by 1,024
Self-citationArmstrong, J. A., & Hart, P. D. (1971) · The Journal of Experimental Medicine · doi:10.1084/jem.134.3.713 · Cited by 990
Impairment of Mycobacterial Immunity in Human Interleukin-12 Receptor Deficiency
Altare, F., Durandy, A., Lammas, D., Emile, J.-F., Lamhamedi, S., Le Deist, F., Drysdale, P., Jouanguy, E., Döffinger, R., Bernaudin, F., et al. (1998) · Science · doi:10.1126/science.280.5368.1432 · Cited by 845
Severe Mycobacterial and Salmonella Infections in Interleukin-12 Receptor-Deficient Patients
Jong, R. D., Altare, F., Haagen, I.-A., Elferink, D. G., Boer, T. D., van Breda Vriesman, P. J. C., Kabel, P. J., Draaisma, J. M. T., van Dissel, J. T., Kroon, F. P., et al. (1998) · Science · doi:10.1126/science.280.5368.1435 · Cited by 821
Variations in the NRAMP1 Gene and Susceptibility to Tuberculosis in West Africans
Bellamy, R., Ruwende, C., Corrah, T., McAdam, K. P. W. J., Whittle, H. C., & Hill, A. V. S. (1998) · New England Journal of Medicine · doi:10.1056/nejm199803053381002 · Cited by 735
Clemens, D. L., & Horwitz, M. A. (1995) · The Journal of experimental medicine · doi:10.1084/jem.181.1.257 · Cited by 687
Caruso, A. M., Serbina, N. V., Klein, E. C., Triebold, K. J., Bloom, B. R., & Flynn, J. L. (1999) · PubMed · Cited by 489
Compensatory ahp C Gene Expression in Isoniazid-Resistant Mycobacterium tuberculosis
Sherman, D. R., Mdluli, K., Hickey, M. J., Arain, T. M., Morris, S. L., Barry, C. E., & Stover, C. K. (1996) · Science · doi:10.1126/science.272.5268.1641 · Cited by 436
Self-citationBellamy, R., Ruwende, C., Corrah, T., McAdam, K. P. W. J., Thursz, M., Whittle, H. C., & Hill, A. V. S. (1999) · The Journal of Infectious Diseases · doi:10.1086/314614 · Cited by 436
Caruso, A. M., Serbina, N., Klein, E., Triebold, K., Bloom, B. R., & Flynn, J. L. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.9.5407 · Cited by 418
An Outbreak Involving Extensive Transmission of a Virulent Strain of Mycobacterium tuberculosis
Valway, S. E., Sanchez, M. P. C., Shinnick, T. F., Orme, I., Agerton, T., Hoy, D., Jones, J. S., Westmoreland, H., & Onorato, I. M. (1998) · New England Journal of Medicine · doi:10.1056/nejm199803053381001 · Cited by 386
Wynn, T. A., Eltoum, I., Cheever, A. W., Lewis, F. A., Gause, W. C., & Sher, A. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.151.3.1430 · Cited by 330
Genetic susceptibility to tuberculosis in Africans: A genome-wide scan
Bellamy, R., Beyers, N., McAdam, K. P. W. J., Ruwende, C., Gie, R., Samaai, P., Bester, D., Meyer, M., Corrah, T., Collin, M., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.140201897 · Cited by 308
Manca, C., Tsenova, L., Barry, C. E., Bergtold, A., Freeman, S., Haslett, P. A. J., Musser, J. M., Freedman, V. H., & Kaplan, G. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.11.6740 · Cited by 306
Self-citationCousens, L. P., Orange, J. S., Su, H. C., & Biron, C. A. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.2.634 · Cited by 304
Interferon α/β-mediated inhibition and promotion of interferon γ: STAT1 resolves a paradox
Nguyen, K. B., Cousens, L. P., Doughty, L. A., Pien, G. C., Durbin, J. E., & Biron, C. A. (2000) · Nature Immunology · doi:10.1038/76940 · Cited by 303
Proinflammatory and Immunoregulatory Functions of Interleukin-12
Trinchieri, G. (1998) · International Reviews of Immunology · doi:10.3109/08830189809043002 · Cited by 290
Cousens, L. P., Peterson, R., Hsu, S., Dorner, A., Altman, J. D., Ahmed, R., & Biron, C. A. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.8.1315 · Cited by 290
Tascon, R. E., Stavropoulos, E., Lukacs, K. V., & Colston, M. J. (1998) · Infection and Immunity · doi:10.1128/iai.66.2.830-834.1998 · Cited by 228
T cell cytokine responses in persons with tuberculosis and human immunodeficiency virus infection.
Zhang, M., Gong, J., Iyer, D. V., Jones, B. E., Modlin, R. L., & Barnes, P. F. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117611 · Cited by 202
A Method for the Large Scale Production of Potent Interferon Preparations
Tovey, M. G., Begon-Lours, J., & Gresser, I. (1974) · Experimental Biology and Medicine · doi:10.3181/00379727-146-38196 · Cited by 182
Self-citationSerbina, N. V., & Flynn, J. L. (1999) · Infection and Immunity · doi:10.1128/iai.67.8.3980-3988.1999 · Cited by 174
Dahl, K. E., Shiratsuchi, H., Hamilton, B. D., Ellner, J. J., & Toossi, Z. (1996) · Infection and Immunity · doi:10.1128/iai.64.2.399-405.1996 · Cited by 172
Fulton, S. A., Johnsen, J. M., Wolf, S. F., Sieburth, D. S., & Boom, W. H. (1996) · Infection and Immunity · doi:10.1128/iai.64.7.2523-2531.1996 · Cited by 159
Laochumroonvorapong, P., Wang, J., Liu, C. C., Ye, W., Moreira, A. L., Elkon, K. B., Freedman, V. H., & Kaplan, G. (1997) · Infection and Immunity · doi:10.1128/iai.65.1.127-132.1997 · Cited by 138
Self-citationYuan, Y., Crane, D. C., Musser, J. M., Sreevatsan, S., & Barry, C. E. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.15.10041 · Cited by 94
Self-citationMattner, J., Schindler, H., Diefenbach, A., Röllinghoff, M., Gresser, I., & Bogdan, C. (2000) · European Journal of Immunology · doi:10.1002/1521-4141(2000)30:8<2257::aid-immu2257>3.0.co;2-u · Cited by 69
Interaction ofMycobacterium aviumwith Human Monocyte-Derived Dendritic Cells
Mohagheghpour, N., van Vollenhoven, A., Goodman, J. R., & Bermudez, L. E. (2000) · Infection and Immunity · doi:10.1128/iai.68.10.5824-5829.2000 · Cited by 47
Aerosol Infection of Mice with Mycobacteria Using a Nose-Only Exposure Device
Tsenova, L., Moreira, A. L., Party, E., Freedman, V. H., & Kaplan, G. (1997) · Applied Biosafety · doi:10.1177/109135059700200307 · Cited by 17
Self-citation
Cited by
Type I interferons in infectious disease
McNab, F., Mayer-Barber, K., Sher, A., Wack, A., & O'Garra, A. (2015) · Nature Reviews Immunology · doi:10.1038/nri3787 · Cited by 2,780
An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis
Berry, M. P. R., Graham, C. M., McNab, F. W., Xu, Z., Bloch, S. A. A., Oni, T., Wilkinson, K. A., Banchereau, R., Skinner, J., Wilkinson, R. J., et al. (2010) · Nature · doi:10.1038/nature09247 · Cited by 1,898
The Immune Response in Tuberculosis
O'Garra, A., Redford, P. S., McNab, F. W., Bloom, C. I., Wilkinson, R. J., & Berry, M. P. R. (2013) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032712-095939 · Cited by 1,342
Pai, M., Behr, M. A., Dowdy, D., Dheda, K., Divangahi, M., Boehme, C. C., Ginsberg, A., Swaminathan, S., Spigelman, M., Getahun, H., et al. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.76 · Cited by 1,270
Mycobacterium tuberculosis Pathogenesis and Molecular Determinants of Virulence
Smith, I. (2003) · Clinical Microbiology Reviews · doi:10.1128/cmr.16.3.463-496.2003 · Cited by 1,154
Metadata
- Authors
- Manca, C., Tsenova, L., Bergtold, A., Freeman, S., Tovey, M., Musser, J. M., Barry, C. E., Freedman, V. H., & Kaplan, G.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2001-04-24
- Volume
- 98
- Issue
- 10
- Pages
- 5752-5757
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2065217848
- Cited by
- 595
- References
- 32
- FWCI
- 13.09
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.